Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8896 |
High Similarity |
NPD2801 |
Approved |
0.8706 |
High Similarity |
NPD7473 |
Discontinued |
0.8639 |
High Similarity |
NPD6232 |
Discontinued |
0.8554 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8457 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8452 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8412 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8391 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8354 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8333 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8218 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8218 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8182 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8132 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8079 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8057 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8034 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8034 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7964 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7964 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7941 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD919 |
Approved |
0.7919 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7874 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7758 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7754 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD3226 |
Approved |
0.767 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7661 |
Intermediate Similarity |
NPD920 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7634 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD943 |
Approved |
0.7605 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7596 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6099 |
Approved |
0.759 |
Intermediate Similarity |
NPD2796 |
Approved |
0.759 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7557 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7545 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7544 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7474 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7473 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD37 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7427 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7416 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7416 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.735 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7323 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD3748 |
Approved |
0.731 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7243 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7176 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7176 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7143 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7136 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7066 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7033 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7022 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7 |
Intermediate Similarity |
NPD7240 |
Approved |
0.6979 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD6190 |
Approved |
0.697 |
Remote Similarity |
NPD1470 |
Approved |
0.6964 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD2403 |
Approved |
0.6933 |
Remote Similarity |
NPD1201 |
Approved |
0.6931 |
Remote Similarity |
NPD7680 |
Approved |
0.6919 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD2494 |
Approved |
0.6915 |
Remote Similarity |
NPD2493 |
Approved |
0.6914 |
Remote Similarity |
NPD7003 |
Approved |
0.6914 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6887 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD9494 |
Approved |
0.6882 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6878 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6869 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6869 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6864 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD3268 |
Approved |
0.6848 |
Remote Similarity |
NPD4749 |
Approved |
0.6848 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6842 |
Remote Similarity |
NPD1933 |
Approved |
0.6836 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD3452 |
Approved |
0.6832 |
Remote Similarity |
NPD3450 |
Approved |
0.6831 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6829
|
Remote Similarity |
NPD7584 |
Approved |